Even as labs contemplate reopening—if and when federal and local governments ease lockdown restrictions—the challenges will be enormous.
Madagascar’s President Andry Rajoelina has expressed an interest in an unproven treatment.
Physicians are grappling with trying to carry out large, international trials in the midst of coronavirus lockdowns.
One of the first people to be diagnosed with COVID-19 in the United States hopes a legacy of her nightmare—the antibodies it left in her blood—will lead to a drug that can help others infected with the virus.
Relying on encouraging if scant data—and the reassuring knowledge that very few children get severely ill from COVID-19—some governments are beginning to reopen schools.
China is facing pressure to open its doors to an independent, international investigation into the origins of the novel coronavirus.
As COVID-19 spreads closer to endangered great apes in Africa and Asia, researchers and veterinarians are gearing up to protect the apes as well as local people.
Health professionals have little time to waste in responding to the coronavirus crisis, and child psychologists are no exception.
The research community is reacting with alarm and anger to the National Institutes of Health’s (NIH’s) abrupt and unusual termination of a grant supporting research in China on how coronaviruses—such as the one causing the current pandemic—move from bats to humans.
The NIH announced a $1.5 billion initiative to speed breakthroughs in diagnostic tests for the virus that causes COVID-19.
A candidate treatment for COVID-19 has shown convincing—albeit modest—benefit for the first time.
Christian Drosten is one of the world’s foremost experts on coronaviruses; his career has closely tracked their emergence as a global threat. Now, he is also a popular—if nerdy—hero.